<?xml version="1.0"?><rss version="2.0"><channel><title>Mary Ann Liebert, Inc., publishers Latest Press Releases</title><link>http://pressroom.prlog.org/jquigley/</link><description>Mary Ann Liebert, Inc., publishers Latest Press Releases</description>
<item><title>MOOCs FORUM Journal Debuts Summer 2013</title><link>http://www.prlog.org/12136618-moocs-forum-journal-debuts-summer-2013.html</link><description>MOOCs FORUM, a new journal, is the only publication dedicated exclusively to the development, design, and deployment of the game-changing Massive Open Online Courses (MOOCs).</description><pubDate>Mon, 13 May 2013 20:50:11 GMT</pubDate></item>
<item><title>Identifying inhibitors of human proteins that promote tumor formation</title><link>http://www.prlog.org/12131043-identifying-inhibitors-of-human-proteins-that-promote-tumor-formation.html</link><description>Tumor repressor genes, which inhibit tumor formation, can be &quot;turned off&quot; due to undesirable molecular changes affecting the chromosomes on which the genes reside.</description><pubDate>Fri, 03 May 2013 20:41:12 GMT</pubDate></item>
<item><title>Predicting the Path to Death and Helping Patients Cope with End-Stage Heart Failure</title><link>http://www.prlog.org/12131037-predicting-the-path-to-death-and-helping-patients-cope-with-end-stage-heart-failure.html</link><description>Congestive heart failure affects more than 5.3 million Americans, is increasing in prevalence, and is ultimately fatal, but the duration and quality of life leading up to death can be unpredictable and vary greatly.</description><pubDate>Fri, 03 May 2013 20:34:31 GMT</pubDate></item>
<item><title>80% of Consumers Want to Buy &quot;Green&quot; Products</title><link>http://www.prlog.org/12125092-80-of-consumers-want-to-buy-green-products.html</link><description>New biobased chemicals and materials, and consumer products derived from renewable resources have a smaller carbon footprint and environmental impact than their petroleum-based alternatives.</description><pubDate>Wed, 24 Apr 2013 17:52:41 GMT</pubDate></item>
<item><title>Nanoparticles Boost Therapeutic Potential of siRNA Drugs</title><link>http://www.prlog.org/12116189-nanoparticles-boost-therapeutic-potential-of-sirna-drugs.html</link><description>New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge.</description><pubDate>Wed, 10 Apr 2013 20:40:48 GMT</pubDate></item>
<item><title>Fat Cells Prolong Survival of Human Stem Cells Grown In Vitro</title><link>http://www.prlog.org/12115083-fat-cells-prolong-survival-of-human-stem-cells-grown-in-vitro.html</link><description>One of the main obstacles that stands in the way of using human hematopoietic stem cells (hHSCs) to treat a variety of diseases is the difficulty growing them in culture—they quickly die or differentiate into other cell types.</description><pubDate>Wed, 10 Apr 2013 20:18:14 GMT</pubDate></item>
<item><title>What Advances Are Driving Clinical Applications of Tissue Engineering and Regenerative Medicine?</title><link>http://www.prlog.org/12108878-what-advances-are-driving-clinical-applications-of-tissue-engineering-and-regenerative-medicine.html</link><description>Explosive growth in the field of tissue engineering and regenerative medicine has led to innovative and promising applications and techniques, many of which are now being tested in human clinical...</description><pubDate>Fri, 29 Mar 2013 19:58:05 GMT</pubDate></item>
<item><title>Are There Limits to What Gene Therapy Can Achieve in Treating Retinal Blindness?</title><link>http://www.prlog.org/12095079-are-there-limits-to-what-gene-therapy-can-achieve-in-treating-retinal-blindness.html</link><description>Follow-up results from one of several groundbreaking gene therapy studies reported in 2008 in patients with an inherited form of retinal blindness confirmed the earlier positive results of substantial improvement in vision.</description><pubDate>Fri, 08 Mar 2013 18:07:51 GMT</pubDate></item>
<item><title>Drug Delivery Strategy Eliminates Myotonia Symptoms in Mice with Myotonic Dystrophy</title><link>http://www.prlog.org/12084947-drug-delivery-strategy-eliminates-myotonia-symptoms-in-mice-with-myotonic-dystrophy.html</link><description>By targeting the specific mutation that causes the hereditary neuromuscular disease myotonic dystrophy, it is possible to neutralize the mutant RNA toxicity and minimize or even eliminate the disabling symptoms of the disease.</description><pubDate>Thu, 21 Feb 2013 22:25:11 GMT</pubDate></item>
<item><title>Noncoding RNAs Offer Huge Therapeutic and Diagnostic Potential</title><link>http://www.prlog.org/12080170-noncoding-rnas-offer-huge-therapeutic-and-diagnostic-potential.html</link><description>As scientists continue to unravel the complexity of the human genome and to uncover vital elements that play a role in both normal physiology and disease, one particular class of elements called noncoding RNAs is gaining a lot of attention.</description><pubDate>Thu, 14 Feb 2013 19:38:40 GMT</pubDate></item>
<item><title>Inaugural issue of Big Data journal Launched at Strata Conference, Santa Clara, CA</title><link>http://www.prlog.org/12079386-inaugural-issue-of-big-data-journal-launched-at-strata-conference-santa-clara-ca.html</link><description>Big Data, the new groundbreaking, open access, peer-reviewed journal published by Mary Ann Liebert, Inc., publishers, will launch its inaugural issue at the Strata conference in Santa Clara, CA, February 26-28, 2013.</description><pubDate>Wed, 13 Feb 2013 19:06:35 GMT</pubDate></item>
<item><title>Resignation of Pope Benedict XVI Demands a Close Look at Rules of Modern Papal Election</title><link>http://www.prlog.org/12079380-resignation-of-pope-benedict-xvi-demands-close-look-at-rules-of-modern-papal-election.html</link><description>The fascinating Conclaves system for electing a new pope, which has been in place since the late 1200s is described in &quot;Creating the Rules of the Modern Papal Election,&quot; published in Election Law Journal from Mary Ann Liebert, Inc., publishers.</description><pubDate>Wed, 13 Feb 2013 19:00:40 GMT</pubDate></item>
<item><title>Robert Lanza Appointed Editor-in-Chiefof BioResearch Open Access journal</title><link>http://www.prlog.org/12077423-robert-lanza-appointed-editor-in-chiefof-bioresearch-open-access-journal.html</link><description>Mary Ann Liebert, Inc., publishers is pleased to announce the appointment of Robert Lanza, MD as Editor-in-Chief of BioResearch Open Access effective immediately.</description><pubDate>Mon, 11 Feb 2013 16:32:48 GMT</pubDate></item>
<item><title>New Space—Preview Issue of Groundbreaking Journal Launched at FA Commercial Space Conference</title><link>http://www.prlog.org/12074900-new-spacepreview-issue-of-groundbreaking-journal-launched-at-fa-commercial-space-conference.html</link><description>Mary Ann Liebert, Inc., publishers announces the preview issue of New Space, the only international peer-reviewed journal dedicated to space innovation and entrepreneurship.</description><pubDate>Wed, 06 Feb 2013 20:29:27 GMT</pubDate></item>
<item><title>New Methods for Quantifying Antisense Drug Delivery to Target Cells and Tissues</title><link>http://www.prlog.org/12071741-new-methods-for-quantifying-antisense-drug-delivery-to-target-cells-and-tissues.html</link><description>Powerful antisense drugs that target disease-associated genes to block their expression can be used to treat a broad range of diseases.</description><pubDate>Fri, 01 Feb 2013 19:10:05 GMT</pubDate></item>
<item><title>Innovative Uses of Nanotechnology in Food and Agriculture Explored in Special Issue</title><link>http://www.prlog.org/12068279-innovative-uses-of-nanotechnology-in-food-and-agriculture-explored-in-special-issue.html</link><description>The U.S. Department of Agriculture (USDA) invests nearly $10 million a year to support about 250 nanoscale science and engineering projects that could lead to revolutionary advances in agriculture and food systems.</description><pubDate>Mon, 28 Jan 2013 20:04:52 GMT</pubDate></item>
<item><title>Novel Aptamer Boosts T Cell-Based Immune Response to Therapeutic Vaccines</title><link>http://www.prlog.org/12065122-novel-aptamer-boosts-cell-based-immune-response-to-therapeutic-vaccines.html</link><description>A small compound called an aptamer that specifically targets and stimulates a human immune cell can greatly increase the effectiveness of an immunotherapeutic drug designed to destroy malignant or virus-infected cells.</description><pubDate>Wed, 23 Jan 2013 15:37:24 GMT</pubDate></item>
<item><title>Exon Skipping to Restore Gene Expression Is Promising Therapeutic Strategy for Muscular Dystrophy</title><link>http://www.prlog.org/12059856-exon-skipping-to-restore-gene-expression-is-promising-therapeutic-strategy-for-muscular-dystrophy.html</link><description>A novel therapeutic approach called exon skipping involves bypassing a disease-causing mutation in a gene to restore normal gene expression and protein production.</description><pubDate>Tue, 15 Jan 2013 18:45:59 GMT</pubDate></item>
<item><title>3D Biomimetic Scaffolds Support Regeneration of Complex Tissues from Stem Cells</title><link>http://www.prlog.org/12057063-3d-biomimetic-scaffolds-support-regeneration-of-complex-tissues-from-stem-cells.html</link><description>Stem cells can be grown on biocompatible scaffolds to form complex tissues such as bone, cartilage, and muscle for repair and regeneration of damaged or diseased tissue.</description><pubDate>Thu, 10 Jan 2013 18:52:35 GMT</pubDate></item>
<item><title>New Rat Model for Muscle Regeneration after Trauma-Related Soft Tissue Injury</title><link>http://www.prlog.org/12052804-new-rat-model-for-muscle-regeneration-after-trauma-related-soft-tissue-injury.html</link><description>Penetrating soft tissue injuries that may be caused by bullet wounds or motor vehicle accidents, or exposure to explosive devices in military settings, can cause muscle loss resulting in functional disability and cosmetic deformity.</description><pubDate>Thu, 03 Jan 2013 21:10:11 GMT</pubDate></item>
<item><title>Targeted Gene Silencing Drugs Are More Than 500 Times More Effective with New Delivery Method</title><link>http://www.prlog.org/12047898-targeted-gene-silencing-drugs-are-more-than-500-times-more-effective-with-new-delivery-method.html</link><description>Small interfering RNAs (siRNAs) are a potent new drug class that can silence a disease-causing gene, but delivering them to a target cell can be challenging.</description><pubDate>Fri, 21 Dec 2012 16:44:48 GMT</pubDate></item>
<item><title>Scale-Up of a Temporary Bioartificial Liver Support System Described in BioResearch Open Access</title><link>http://www.prlog.org/12046240-scale-up-of-temporary-bioartificial-liver-support-system-described-in-bioresearch-open-access.html</link><description>Acute liver failure is usually fatal without a liver transplant, but the liver can regenerate and recover if given time to heal.</description><pubDate>Wed, 19 Dec 2012 15:15:45 GMT</pubDate></item>
<item><title>Is the U.S. Health Care System a Target for Cyberterrorism?</title><link>http://www.prlog.org/12044565-is-the-us-health-care-system-target-for-cyberterrorism.html</link><description>The health care system in the U.S. is a $2.5 trillion industry and depends heavily on communication and the transfer of information via the Internet. This puts it at ever-increasing risk of a cyberterrorism attack.</description><pubDate>Mon, 17 Dec 2012 16:25:56 GMT</pubDate></item>
<item><title>AEESP Names Environmental Engineering Science as its Official Journal</title><link>http://www.prlog.org/12042615-aeesp-names-environmental-engineering-science-as-its-official-journal.html</link><description>The Association of Environmental Engineering and Science Professors (AEESP), has selected the peer-reviewed journal Environmental Engineering Science as its Official Journal.</description><pubDate>Fri, 14 Dec 2012 13:56:48 GMT</pubDate></item>
<item><title>Can Compressed Fluids Increase Enzyme Activity in Industrial Bioprocesses?</title><link>http://www.prlog.org/12038879-can-compressed-fluids-increase-enzyme-activity-in-industrial-bioprocesses.html</link><description>Enzymes play a crucial role as biocatalysts, increasing the speed and efficiency and decreasing the energy consumption of biochemical reactions in many industrial processes.</description><pubDate>Fri, 07 Dec 2012 17:01:13 GMT</pubDate></item>
<item><title>Can a Genetic Variation in the Vitamin D Receptor Protect Against Osteoporosis?</title><link>http://www.prlog.org/12033303-can-genetic-variation-in-the-vitamin-receptor-protect-against-osteoporosis.html</link><description>Osteoporosis, or reduced bone mineral density that can increase the risk of fractures, may affect as many as 30% of women and 12% of men worldwide. One risk factor for osteoporosis is vitamin D deficiency.</description><pubDate>Thu, 29 Nov 2012 16:44:02 GMT</pubDate></item>
<item><title>Is the Detection of Early Markers of Epstein Barr Virus of Diagnostic Value?</title><link>http://www.prlog.org/12025173-is-the-detection-of-early-markers-of-epstein-barr-virus-of-diagnostic-value.html</link><description>Epstein-Barr virus (EBV) is the cause of infectious mononucleosis and a risk for serious disease in liver transplant recipients. Molecular tests that can identify early protein markers produced by EBV may have value for diagnosing active infection.</description><pubDate>Fri, 16 Nov 2012 19:49:26 GMT</pubDate></item>
<item><title>Can the Addition of Radiolabeled Treatments Improve Outcomes in Advanced Metastatic Disease?</title><link>http://www.prlog.org/12022201-can-the-addition-of-radiolabeled-treatments-improve-outcomes-in-advanced-metastatic-disease.html</link><description>Radiolabeled agents are powerful tools for targeting and killing cancer cells and may help improve outcomes and lengthen survival times of patients with advanced disease that has spread beyond the initial tumor site.</description><pubDate>Tue, 13 Nov 2012 15:44:07 GMT</pubDate></item>
<item><title>Teleconcussion--A New, Innovative Strategy for Assessing Young Athletes</title><link>http://www.prlog.org/12019089-teleconcussion-new-innovative-strategy-for-assessing-young-athletes.html</link><description>Concussion is a common disorder estimated to affect no fewer than 1.7-3.8 million people in the U.S. each year.</description><pubDate>Thu, 08 Nov 2012 16:38:01 GMT</pubDate></item>
<item><title>Will New Methods that Increase Blood Flow to Bone Implants...</title><link>http://www.prlog.org/12005811-will-new-methods-that-increase-blood-flow-to-bone-implants.html</link><description>New, advanced techniques are needed that can mimic the normal blood supply that feeds natural bone to improve the viability and success of restorative procedures to replace damaged or diseased bone tissue using engineered constructs.</description><pubDate>Mon, 22 Oct 2012 20:03:57 GMT</pubDate></item>
<item><title>Human Gene Therapy Journal Expands to Cover Clinical Development in Early 2013</title><link>http://www.prlog.org/11998193-human-gene-therapy-journal-expands-to-cover-clinical-development-in-early-2013.html</link><description>Human Gene Therapy is expanding its editorial coverage with the launch of Human Gene Therapy Clinical Development early next year.</description><pubDate>Fri, 12 Oct 2012 16:05:49 GMT</pubDate></item>
<item><title>Articles by Nobel Laureates Sir John Gurdon and Shinya Yamanaka in Stem Cells and Development</title><link>http://www.prlog.org/11998178-articles-by-nobel-laureates-sir-john-gurdon-and-shinya-yamanaka-in-stem-cells-and-development.html</link><description>Mary Ann Liebert, Inc., publishers and the editorial leadership of the peer-reviewed journal Stem Cells and Development congratulate Sir John Gurdon and Shinya Yamanaka on being awarded the Nobel Prize for Physiology or Medicine.</description><pubDate>Fri, 12 Oct 2012 15:54:46 GMT</pubDate></item>
<item><title>GEN Reports on Growth of Biobanking Operations</title><link>http://www.prlog.org/11978945-gen-reports-on-growth-of-biobanking-operations.html</link><description>Many biotech observers maintain that the future of healthcare will largely be based on the field of personalized medicine, reports Genetic Engineering &amp; Biotechnology News (GEN).</description><pubDate>Wed, 19 Sep 2012 18:00:11 GMT</pubDate></item>
<item><title>GEN Reports on Ocular Therapeutics Targeting the Retina</title><link>http://www.prlog.org/11971140-gen-reports-on-ocular-therapeutics-targeting-the-retina.html</link><description>Therapies for retinal diseases are expected to overtake those for glaucoma by 2014, reports Genetic Engineering &amp; Biotechnology News (GEN).</description><pubDate>Mon, 10 Sep 2012 17:24:44 GMT</pubDate></item>
<item><title>Can Videogaming Benefit Young People with Autism Spectrum Disorder?</title><link>http://www.prlog.org/11967318-can-videogaming-benefit-young-people-with-autism-spectrum-disorder.html</link><description>According to the Centers for Disease Control and Prevention (CDC), 1 in 88 children in the U.S. has autism spectrum disorder (ASD), a broad group of neurodevelopmental disorders.</description><pubDate>Wed, 05 Sep 2012 15:19:43 GMT</pubDate></item>
<item><title>Realizing the Promise of RNA Nanotechnology for New Drug Development</title><link>http://www.prlog.org/11966364-realizing-the-promise-of-rna-nanotechnology-for-new-drug-development.html</link><description>The use of RNA in nanotechnology applications is highly promising for many applications, including the development of new therapeutic compounds.</description><pubDate>Tue, 04 Sep 2012 17:55:38 GMT</pubDate></item>
<item><title>Biomass Characterization Technology Research Highlighted in Industrial Biotechnology Journal</title><link>http://www.prlog.org/11962054-biomass-characterization-technology-research-highlighted-in-industrial-biotechnology-journal.html</link><description>Biomass recalcitrance can be overcome through improved methods of biomass characterization.</description><pubDate>Wed, 29 Aug 2012 17:04:52 GMT</pubDate></item>
<item><title>New Marker for Identifying Precursors to Insulin-Producing Cells in Pancreas</title><link>http://www.prlog.org/11954937-new-marker-for-identifying-precursors-to-insulin-producing-cells-in-pancreas.html</link><description>For the millions of people worldwide with type 1 diabetes who cannot produce sufficient insulin, the potential to transplant insulin-producing cells could offer hope for a long-term cure.</description><pubDate>Tue, 21 Aug 2012 14:25:49 GMT</pubDate></item>
<item><title>Prosperous Native American Tribes Grow Anxious About Legalization of Internet Gambling</title><link>http://www.prlog.org/11951457-prosperous-native-american-tribes-grow-anxious-about-legalization-of-internet-gambling.html</link><description>Every year tribal gaming generates billions of dollars in revenue, creates tens of thousands of jobs, and boosts the economies of many Native American communities.</description><pubDate>Thu, 16 Aug 2012 14:28:11 GMT</pubDate></item>
<item><title>Human Embryos Frozen for 18 Years Yield Viable Stem Cells Suitable for Biomedical Research</title><link>http://www.prlog.org/11948326-human-embryos-frozen-for-18-years-yield-viable-stem-cells-suitable-for-biomedical-research.html</link><description>Even after being frozen for 18 years, human embryos can be thawed, grown in the laboratory, and successfully induced to produce human embryonic stem (ES) cells, which represent a valuable resource for drug screening and medical research.</description><pubDate>Mon, 13 Aug 2012 14:02:05 GMT</pubDate></item>
<item><title>U.S. Navy Defends Renewable Fuels Strategy in Industrial Biotechnology Journal</title><link>http://www.prlog.org/11946209-us-navy-defends-renewable-fuels-strategy-in-industrial-biotechnology-journal.html</link><description>Despite criticism from Congressional Republicans and other groups, the U.S. Navy recently completed its Rim of the Pacific (RIMPAC) 2012 international maritime exercises, featuring the “Great Green Fleet” powered by a 50% biofuels blend.</description><pubDate>Thu, 09 Aug 2012 17:03:54 GMT</pubDate></item>
<item><title>Method to Prevent Rejection of Disease-Fighting Proteins Described in Human Gene Therapy Journal</title><link>http://www.prlog.org/11944147-method-to-prevent-rejection-of-disease-fighting-proteins-described-in-human-gene-therapy-journal.html</link><description>The body’s natural reaction to reject replacement proteins represents a major obstacle to the successful use of gene therapy to cure a range of life-threatening diseases.</description><pubDate>Tue, 07 Aug 2012 17:36:13 GMT</pubDate></item>
<item><title>GEN Reports on Recent Progress in Alzheimer’s Research</title><link>http://www.prlog.org/11944142-gen-reports-on-recent-progress-in-alzheimers-research.html</link><description>The global market value of Alzheimer's disease therapeutics could soar to the $8 billion range once therapeutics are approved that actually change the course of the disease, reports Genetic Engineering &amp; Biotechnology News (GEN).</description><pubDate>Tue, 07 Aug 2012 17:30:40 GMT</pubDate></item>
<item><title>Genetic Engineering &amp; Biotechnology News Unveils “Biotech Boulevard”</title><link>http://www.prlog.org/11944137-genetic-engineering-biotechnology-news-unveils-biotech-boulevard.html</link><description>Genetic Engineering &amp; Biotechnology News (GEN) has launched a unique microsite called Biotech Boulevard.</description><pubDate>Tue, 07 Aug 2012 17:27:04 GMT</pubDate></item>
<item><title>Should High-Dose Interleukin-2 Continue to be the Treatment of Choice for Metastatic Melanoma?</title><link>http://www.prlog.org/11934802-should-high-dose-interleukin-2-continue-to-be-the-treatment-of-choice-for-metastatic-melanoma.html</link><description>Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma.</description><pubDate>Thu, 26 Jul 2012 14:44:16 GMT</pubDate></item>
<item><title>New Gene Therapy Strategy Boosts Levels of Deficient Protein in Friedreich’s Ataxia</title><link>http://www.prlog.org/11933682-new-gene-therapy-strategy-boosts-levels-of-deficient-protein-in-friedreichs-ataxia.html</link><description>A novel approach to gene therapy that instructs a person’s own cells to produce more of a natural disease-fighting protein could offer a solution to treating many genetic disorders.</description><pubDate>Wed, 25 Jul 2012 14:30:23 GMT</pubDate></item>
<item><title>Novel Pig Model May Be Useful for Human Cancer Studies</title><link>http://www.prlog.org/11932749-novel-pig-model-may-be-useful-for-human-cancer-studies.html</link><description>A naturally occurring line of immunodeficient pigs can support the growth of human tumors injected under their skin, offering a promising new large animal model for studying human cancers and testing new drugs and treatment strategies.</description><pubDate>Tue, 24 Jul 2012 16:34:03 GMT</pubDate></item>
<item><title>Strategies to Improve Renewable Energy Feedstocks for Co-Firing with Coal</title><link>http://www.prlog.org/11928976-strategies-to-improve-renewable-energy-feedstocks-for-co-firing-with-coal.html</link><description>To enable greater reliance on renewable biomass resources for power generation, combination approaches such as co-firing of high percentages of biomass with coal offer unique advantages, but also significant challenges.</description><pubDate>Thu, 19 Jul 2012 16:04:33 GMT</pubDate></item>
<item><title>New Therapeutic Target for Prostate Cancer Identified</title><link>http://www.prlog.org/11926685-new-therapeutic-target-for-prostate-cancer-identified.html</link><description>A small, naturally occurring nucleic acid sequence, called a microRNA, known to regulate a number of different cancers, appears to alter the activity of the androgen receptor, which plays a critical role in prostate cancer.</description><pubDate>Tue, 17 Jul 2012 14:57:37 GMT</pubDate></item>
<item><title>Can Robots Improve Patient Care in the ICU?</title><link>http://www.prlog.org/11920751-can-robots-improve-patient-care-in-the-icu.html</link><description>Remote presence robots are used in intensive care units (ICUs) to help critical care physicians supplement on-site patient visits and maintain more frequent patient interactions.</description><pubDate>Tue, 10 Jul 2012 17:51:44 GMT</pubDate></item></channel></rss>